AstraZeneca Stock Fell Over 2% in Premarket Trading.
Japan canceled a third of contracted AstraZeneca COVID-19 vaccine purchase.
Japan has canceled the purchase of about 40 million AstraZeneca Plc COVID-19 vaccine doses it agreed to buy last year, a health ministry official said in parliament on Monday.
The contract allowed the government to cancel a portion of the supply if it was unneeded, the official said in response to lawmakers' questioning. Japan had originally agreed to buy 120 million of the shots, with the bulk made domestically by Daiichi Sankyo Co. and other local partners.
About Astrazeneca 200,000 doses have been supplied to local governments in Japan, while 63 million doses have donated overseas, the official added.
Japan has predominantly relied on the mRNA-type vaccines developed by Pfizer Inc and Moderna Inc for its COVID inoculations and boosters so far.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments